#$%^&*AU2016247097A120170601.pdf#####TREATMENT OF VAGINITIS ABSTRACT The invention relates to the treatment of vaginal mycoses, bacterial vaginoses, and other forms of the vaginitis (inflammation of the vagina). Used externally for this purpose in 5 accordance with the invention is clinoptilolite having a particle size of between 0.2 and 10 im in the treatment of these vaginal disorders in mammals and humans, and also for restoring the healthy vaginal microbiota. The clinoptilolite may be used with one or more of the following adjuvants: 10 phannaceutically acceptable carrier materials, viable microorganisms and/or extracts thereof, nutrients for the healthy vaginal microbiota (e.g. lactose, etc.), substances which favorably influence the vaginal environment for the healthy vaginal microbiota (e.g. estradiol, organic acids, etc.). is The composition used may be applied locally, preferably in one of the following administration forms: foam, suppository, vaginal tablet, ovule, gel, aerosol, powder, rinse, douche, cream/ointment, suspension.
